Campto, Topotesin: Clinical Trials

2 trials of Campto, Topotesin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended, 1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Suspended 1

Follow Campto, Topotesin: new trials by email Literature Review of Campto, Topotesin trials Research Report on Campto, Topotesin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Campto, Topotesin, TS-1, L-Plat - Metastatic Colorectal Cancer
Phase 3SuspendedHokkaido Gastrointestinal Cancer Study Group2002006-04-012007-11-01
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
Campto, Topotesin, TS-1 - Colorectal Cancer
Phase 2UnknownHokkaido Gastrointestinal Cancer Study Group402004-01-012007-11-01

Conditions studied

Colorectal Neoplasms (2)

Sponsors

Hokkaido Gastrointestinal Cancer Study Group (2)

Countries

Japan (2)

Top investigators

Yoshito Komatsu, MD, PhD (1)  ·  Yoshito Komatsu, MD.PhD (1)